| Last Trade | 133.50 |
| Change | 3.10 |
| Change (%) | 2.38 |
| Open | 130.40 |
| Low | 128.60 |
| High | 134.10 |
| Prev. Close | 130.40 |
| Change (3M) | 6.37 % |
| Change (6M) | (11.41 %) |
| Volume | 171,758 |
| Turnover | 22,748,072.00 |
| Transactions | 2,577 |
| Market Value | 13,560.26 |
| Avg. Volume (3M) | 144,929.07 |
| Avg. Turnover (3M) | 16,098,752.17 |
| Avg. Transaction (3M) | 1,701.71 |
| Change (12M) | 5.45 % |
| YTD | 6.37 % |
|
Event Date
|
Event
|
||
|---|---|---|---|
|
07-04-2026
|
Cash Dividend Distribution | ||
|
24-03-2026
|
Ex-dividend Date | ||
|
30-11-2025
|
Cash Dividend Distribution | ||
|
10-11-2025
|
Ex-dividend Date | ||
|
19-10-2025
|
General Assembly | ||
| More | |||
| Report | Interim | Year |
| Dallah Healthcare earns SAR 538.3M in 2025, SAR 116.6 M in Q4 | 12 M | 2025 |
| Dallah earns SAR 421.7M in 9M 2025, SAR 141.9M in Q3 | 9 M | 2025 |
| Dallah H1 2025 profit up 21% to SAR 279.8M; Q2 at SAR 124.3M | 6 M | 2025 |
| Dallah profit jumps 30% to SAR 155.6M in Q1 2025 | 3 M | 2025 |
| Date | Research firm | Rating |
|
|
U-Capital | Buy |
|
|
AlphaMena | Underweight |
|
|
U-Capital | Hold |
|
|
AlJazira Capital | Neutral |
